BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37304895)

  • 1. Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma.
    Lee YP; Yoon SE; Cho J; Ko YH; Oh D; Ahn YC; Kim WS; Kim SJ
    Cancer Manag Res; 2023; 15():463-474. PubMed ID: 37304895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
    Mannisto S; Vähämurto P; Pollari M; Clausen MR; Jyrkkiö S; Kellokumpu-Lehtinen PL; Kovanen P; Karjalainen-Lindsberg ML; d'Amore F; Leppä S
    Eur J Cancer; 2019 Jul; 115():27-36. PubMed ID: 31082690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
    Ollila TA; Olszewski AJ
    Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience.
    Kim J; Yoon DH; Park I; Kim S; Park JS; Lee SW; Huh J; Park CS; Suh C
    Blood Res; 2014 Sep; 49(3):170-6. PubMed ID: 25325036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
    Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E
    J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histological features of primary testicular diffuse large B-cell lymphoma: a single center experience in China.
    Zhou D; Bao C; Ye X; Zhu L; Zhu J; Li L; Zhu M; Yang X; Zheng Y; Huang X; Xie M; Xie W
    Oncotarget; 2017 Dec; 8(68):112384-112389. PubMed ID: 29348832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
    Linassier C; Desablens B; Lefrancq T; Le Prise PY; Harousseau JL; Jacob C; Gandhour C; Haillot O; Lucas V; Leloup R; Escoffre M; Colombat P; Tabuteau S;
    Clin Lymphoma; 2002 Dec; 3(3):167-72. PubMed ID: 12521394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary testicular lymphoma: Clinical characteristics and oncological outcomes.
    Medina AA; Lorca Álvaro J; Carretero Del Barrio I; Laso García I; García Cosío M; Mata Alcaraz M; Hevia Palacios M; Gómez Dos Santos V; Burgos Revilla FJ
    Curr Urol; 2023 Jun; 17(2):130-134. PubMed ID: 37691992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
    Kridel R; Telio D; Villa D; Sehn LH; Gerrie AS; Shenkier T; Klasa R; Slack GW; Tan K; Gascoyne RD; Connors JM; Savage KJ
    Br J Haematol; 2017 Jan; 176(2):210-221. PubMed ID: 27739058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
    Zouhair A; Weber D; Belkacémi Y; Ketterer N; Dietrich PY; Villà S; Scandolaro L; Bieri S; Studer G; Delacretaz F; Girardet C; Mirimanoff RO; Ozsahin M;
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):652-6. PubMed ID: 11849786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
    Kansara R
    Curr Treat Options Oncol; 2018 Sep; 19(11):52. PubMed ID: 30203318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
    Guirguis HR; Cheung MC; Mahrous M; Piliotis E; Berinstein N; Imrie KR; Zhang L; Buckstein R
    Br J Haematol; 2012 Oct; 159(1):39-49. PubMed ID: 22849793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival.
    Ichikawa K; Noguchi M; Koike M; Aritaka N; Sekiguchi Y; Sunami Y; Tsutsui M; Hosone M; Hirano T; Gotoh A; Komatsu N
    Int J Hematol; 2014 Oct; 100(4):370-8. PubMed ID: 25085255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China.
    Chen B; Cao DH; Lai L; Guo JB; Chen ZY; Huang Y; Qiu S; Lin TH; Gou Y; Ma N; Yang L; Liu LR; Wei Q
    BMC Cancer; 2020 Mar; 20(1):220. PubMed ID: 32171265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma.
    Chen GL; Li D; Cao S; Jiang S; Zhang Q; Jin J; Xia Z; Liu Y; Liu X; Zhu Y; Chen Y; Gu L; Hong X; Cao J; Tao R; Lv F
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022066. PubMed ID: 36119461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of survival and treatment outcome of patients with primary diffuse large B cell lymphoma in reproductive system].
    Yang P; Zhen JF; Pang M; Hu K; Zhao W; Dong F; Tian L; Ke XY; Jing HM
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(20):1593-1596. PubMed ID: 29886651
    [No Abstract]   [Full Text] [Related]  

  • 19. Diffuse large-cell lymphoma of the testis.
    Tondini C; Ferreri AJ; Siracusano L; Valagussa P; Giardini R; Rampinelli I; Bonadonna G
    J Clin Oncol; 1999 Sep; 17(9):2854-8. PubMed ID: 10561362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consideration of aggressive therapeutic strategies for primary testicular lymphoma.
    Park BB; Kim JG; Sohn SK; Kang HJ; Lee SS; Eom HS; Kwon HC; Oh SY; Kang JH; Oh SJ; Shin HJ; Suh C; Kim JH; Kim HY; Kim K; Ryoo BY; Kim WS
    Am J Hematol; 2007 Sep; 82(9):840-5. PubMed ID: 17563078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.